You are here

Reactive Metabolites in Diabetes Study Group Symposium: Reactive metabolites and increased risk of severe COVID-19 disease in obesity and diabetes

Tuesday, 28 September 2021, 16:00 - 17:00, Berlin Hall

Chairs: N. Rabbani, QA; M. Al-Asmakh, QA

A. Ceriello, IT: Could increased reactive oxygen species (ROS) contribute to severe COVID-19 in obesity and diabetes?

P.J. Thornally, QA: Increased methylglyoxal in obesity and diabetes – friend or foe of SARS-CoV2?